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Hepatocellularcarcinomararelymetastasizestotheorbit.Wereporta45-year-oldmale,HBV+,HIV+,withapasthistoryofaliver
transplantforELSD(end-stageliverdisease)withhepatocellularcarcinomaandrecurrentHCC,whopresentedwithproptosisand
diplopiaofthelefteye.CTscansoftheheadrevealedalarge,irregularmassintheleftorbitcausingsuperiorandlateraldestruction
of the orbital bone. Biopsy specimens of the orbital tumor showed features of metastatic foci of hepatocellular carcinoma. Only 16
other cases of HCC metastasis to the orbit have been described in literature, and this is the ﬁrst case in a previously transplanted
HIV+, HBV+ patient.
1.Introduction
Hepatocellular carcinoma (HCC) accounts for 85–90% of all
primarylivercancers.Eachyear,approximatelyhalfamillion
people worldwide are newly diagnosed with HCC. The ma-
jority of HCC cases develop on a substrate of chronic hepati-
tis B (HBV) and C virus (HCV) infection.
ESLD (end-stage liver disease) and HCC are increas-
ing causes of mortality in human-immunodeﬁciency-virus-
(HIV-) seropositive patients. Coinfection with HIV may ac-
celerate the progression of chronic HBsAg-positive hepatitis
tocirrhosisandmayfostertherapidprogressionofregenera-
tivenodulestodysplasticnodulesandHCC.OLT(orthotopic
liver transplantation) in HIV patients with ESLD with or
without HCC is an emerging option in this set of patients,
especially since the administration of HAART can guarantee
a good viral-immunological framework.
Approximately 50%–75% of patients with HCC develop
metastases during the disease course [1]. The most common
sites of metastatic disease are the lung (41.4–51.6%), the
regional lymph nodes (26.7–37.9%), and less commonly,
the adrenal glands (5.8–10.9%), bones (4.8–8.8%), gallblad-
der (4.3–11.6%), and peritoneum (4.0–10.9%) [2]. Orbital
metastases from HCC are extremely rare, and only 16 cases
have been reported in the literature.
We report a case of orbital metastasis from HCC in a
45-year-old HCV+, HIV+ male with a past history of a liver
transplant for hepatocellular carcinoma, and recurrent HCC
subjected to multiple therapies.
2.CaseReport
A 45-year-old man presented to our department in Decem-
ber 2010 with proptosis of the left eye lasting about one
month (Figure 1(a)). He complained of diplopia but no pain
or redness. His right eye was unremarkable. His best cor-
rected visual acuity was 20/20 in both eyes. On examination,
he had a 6mm proptosis in the left eye, and an inferior
displacement of the eye with superior sulcus fullness. A solid
mass was palpable in the superior part of the orbit, not2 Case Reports in Ophthalmological Medicine
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Figure 1: (a) Proptosis of the left eye, (b), (c), and (d) computed tomography (CT) scans of the orbit that showed an extraconal mass
involvingthesuperiorandlateralwalloftheleftorbitwithdestructionoftheorbitalbone,incorporatingthelateralrectus,withcalciﬁcations.
separable from the superior orbital rim. The left eye motility
was restricted in the upward and leftward gaze.
His past medical history was positive for HIV and HBV
infection since 1986 and consequent cirrhosis and hepato-
cellular carcinoma (HCC). In July 2006, he had undergone
a liver transplant for ESLD with concomitant HCC, with
a marginal organ. Histologic evaluation of the native liver
pointed out the presence of a cancer thrombus within the
right branch of the portal vein.
In December 2008, he was subjected to a partial surgical
resection of the transplanted liver for a recurrence of HCC.
He started therapy with sorafenib in 2009, but took the
drug irregularly and reduced the dosage for the concomitant
occurrence of diarrhea.
H ep r e s e n t e dan e wl i v e ra n dp u l m o n a r yr e c u r r e n c ei n
December 2009. The liver recurrence was treated with selec-
tive transarterial chemoembolization, while the pulmonary
metastases were treated by local resection of the middle
lobe of the left lung. After histological examination of
the pulmonary lesions conﬁrmed the HCC recurrence,
the patient started systemic chemotherapy with liposomial
doxorubicin. In July 2010, the patient presented a new HCC
recurrence to the lungs and liver and therefore underwent
level II chemotherapy with 5-FU and subsequently with
capecitabine. In December 2010, he presented with proptosis
and diplopia of the left eye, and AFP was high: 3750ng/mL.
On the suspicion of an orbital metastasis of HCC, the patient
underwent computed tomography (CT) scans of the orbit
that showed an extraconal mass involving the superior and
lateral wall of the left orbit with destruction of the orbital
bone, incorporating the lateral rectus, with calciﬁcations
(Figures1(a),1(c),and1(d)).Percutaneousincisionalbiopsy
of the lesion was performed.
3.Pathological Findings
Microscopic examination showed a diﬀuse inﬁltrate of large
polygonal cells with a ﬁnely eosinophilic cytoplasm and
roundish-oval hyperchromatic nuclei containing one or a
few large nucleoli. The growth pattern was trabecular with
theformationofoccasionalwell-deﬁnedlumina.Thenuclear
pleomorphism and mitotic activity were moderate (Fig-
ure2(a)).Theneoplasticcellsstainedpositivelywithperiodic
acid Schiﬀ (Figure 2(b)) and showed a strong, diﬀuse immu-
noreactivity for OCH1E5 and CK20 (Figure 2(c)). CK7,
CEA, and α-fetoprotein were negative.
At electron microscopy, the neoplastic cells were fairly
uniform in shape, size, and structure. They contained nu-
merous mitochondria, a well-developed rough endoplasmic
reticulum, intracytoplasmic bile products, and abundant
glycogen. Bile canaliculi with stubby microvilli and cell junc-
tions were also evident (Figure 2(d)). The patient was treated
with local radiotherapy.
4. Discussion
A mass in the orbit is rarely a case of metastasis, featured
in only 3–9% of all orbital tumors [3]. Moreover, the mostCase Reports in Ophthalmological Medicine 3
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Figure 2: (a) The tumor is composed of cords of cells resembling hepatocytes surrounded by a looser hypocellular ﬁbrous stroma
containing prominent sinusoidal vessels. (E.E, 100x). (b) Semithin section: polygonal cells in trabecular pattern, with large nuclei and
prominent nucleoli and many intracytoplasmic small vesicles (Polychr. sec. Tolivia, 400x). (c) The neoplastic cells showed strong and diﬀuse
immunoreactivity for OCH1E5. (I.I.C., 400x). (d) Electron microscopic appearance: malignant hepatocytes with numerous mitochondria,
abundant glycogen, and large nuclei with prominent nucleoli. Bile canaliculi with stubby microvilli and cell junctions were also evident
(TEM, 1800x).
common primary sites of orbital metastases are the breast,
the lung, the genitourinary, and the gastrointestinal tract
[3]. Clinically diagnosed cases of HCC to the orbit are
rare; only 16 cases of HCC metastasizing to the orbit have
been reported. The mechanism of metastasis to the orbit is
diﬃcult to determine. A hematogenous route, as for other
primary neoplasms of the abdomen, may be suspected [4].
Tumor cells may circulate through the vena cava, beyond the
pulmonary ﬁlter to the heart, and ﬁnally being distributed
to the orbital region through the arterial systemic circulation
[2]. Other authors have reported that tumor cells can reach
the head and the neck by bypassing the lungs, possibly
through the vertebral venous plexus of Baston [5]. In the
present case, the presence of pulmonary metastases leads us
to speculate that the ﬁrst pathway, through the pulmonary
ﬁlter, may have contributed to this orbital metastasis. Fur-
thermore, when studying the establishment of orbital metas-
tases, we must consider the possibility of inﬁltration to the
orbit secondary to metastasis to the orbital bones [6]. In
ourpatient,therewasmarkedcranialdestruction,suggesting
the possibility of extension to the orbit secondary to cranial
metastases.
The clinical manifestations of metastatic carcinoma are
proptosis, ophthalmoplegia, diplopia and acquired strabis-
mus, conjunctival hyperemia, pain, and diminished vision if
the tumor inﬁltrates the choroids [2, 3].
The histopathological diagnosis of HCC is based on the
presence of large, polygonal cells, a trabecular pattern, and
endothelial cuﬃng. Diﬀerential diagnosis must be made for
renalcellcarcinoma,thatcanbepresentwithsimilarcytolog-
ical features and architecture, and also shows similar staining
for cytokeratins [7] .T h et w om a ybed i ﬀerentiated by the use
of carcinoembryonic antigen and alfa-fetoprotein [8]. Other
diseases to be considered in the diﬀerential diagnosis are
hepatoid carcinoma of the stomach, lung, and ovary, giant
cell carcinoma of the lung, and breast carcinoma, [9]a sw e l l
as melanoma.
The diagnosis of HCC metastases can be conﬁrmed by
the use of immunohistochemistry [10]. HCC metastases can
be treated by surgery, radiotherapy, and chemotherapy as in
our case, but prognosis is generally poor.
Recently, therapy for advanced HCC was revolutionized
by the advent of Sorafenib, a multikinase inhibitor with an
antiangiogenic activity targeting the VEGF pathway. Rapa-
mycin, also used as an immunosuppressant in this patient,4 Case Reports in Ophthalmological Medicine
showed a strongly increased antiproliferative activity target-
ing the m-Tor pathway in HCC, when paired with Nexavar.
Two recent reports have pointed out that discontinuous,
low-dose treatment with antiangiogenics might elicit tumor
invasiveness and metastasis [11–13].
Many factors in this patient may have contributed to this
unusual presentation of HCC metastasis: the immunosup-
pression caused by HIV infection, the documented invasion
of the vascular bed by HCC on removal of the liver, and
the possibility of pulmonary metastasis of HCC (previously
documented in a series of 11 patients with rare brain
metastases of HCC, in which lung metastasis was present in
91%).
Although orbital metastases are rare, the ophthalmolo-
gist should be aware of this clinical form and prognostic im-
plications (especiallyin patients previously treated with anti-
angiogenic therapy) and make eﬀorts to palliate the patient’s
symptoms as far as possible.
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